Parallax Volatility Advisers, L.P. Ptc Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $1.01 Million - $1.89 Million	45,000 New	45,000 $1.01 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $2.35 Million - $3.84 Million	70,000 New	70,000 $2.67 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $2.96 Million - $5.51 Million	-115,000 Reduced 65.71%	60,000 $2.02 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $3.06 Million - $5.7 Million	175,000 New	175,000 $4.74 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.